Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2013 1
2016 1
2021 1
2022 1
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean qiu kang fu (1 results)?
Repurposing AS1411 for constructing ANM-PROTACs.
Fu X, Li J, Chen X, Chen H, Wang Z, Qiu F, Xie D, Huang J, Yue S, Cao C, Liang Y, Lu A, Liang C. Fu X, et al. Among authors: qiu f. Cell Chem Biol. 2024 Apr 12:S2451-9456(24)00127-2. doi: 10.1016/j.chembiol.2024.03.011. Online ahead of print. Cell Chem Biol. 2024. PMID: 38657608
Randomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
Lin HX, Hua YJ, Chen QY, Luo DH, Sun R, Qiu F, Mo HY, Mai HQ, Guo X, Xian LJ, Hong MH, Guo L. Lin HX, et al. Among authors: qiu f. Chin J Cancer. 2013 Sep;32(9):502-11. doi: 10.5732/cjc.013.10004. Epub 2013 Jul 2. Chin J Cancer. 2013. PMID: 23816561 Free PMC article. Clinical Trial.
Patients with biopsy-diagnosed untreated stages III and IV NPC (according to the 2002 UICC staging system) were randomized to undergo 2 cycles of sinusoidal chronomodulated infusion (Arm A) or flat intermittent constant rate infusion (Arm B) of DDP and 5-FU followed by rad …
Patients with biopsy-diagnosed untreated stages III and IV NPC (according to the 2002 UICC staging system) were randomized to undergo 2 cycl …
Circadian rhythm in dihydropyrimidine dehydrogenase activity and reduced glutathione content in peripheral blood of nasopharyngeal carcinoma patients.
Zeng ZL, Sun J, Guo L, Li S, Wu MW, Qiu F, Jiang WQ, Lévi F, Xian LJ. Zeng ZL, et al. Among authors: qiu f. Chronobiol Int. 2005;22(4):741-54. doi: 10.1080/07420520500179969. Chronobiol Int. 2005. PMID: 16147904
Dihydropyrimidine dehydrogenase (DPD) is a rate-limiting enzyme of 5-fluorouracil (5-FU) catabolism. Glutathione (GSH) is a tripeptide involved in platinum complex detoxification. ...These findings imply that the chronotherapeutic schedule of 5-FU and platinum used …
Dihydropyrimidine dehydrogenase (DPD) is a rate-limiting enzyme of 5-fluorouracil (5-FU) catabolism. Glutathione (GSH) is a tripeptid …
[Phase I clinical trial evaluation of capecitabine in concurrent combination of radiotherapy in nasopharyngeal carcinoma].
Jiang Y, Hong MH, Deng MQ, Guo L, Cao KJ, Mo HY, Qiu F, Mai HQ, Chen QY, Sun R, Luo DH, Huang PY. Jiang Y, et al. Among authors: qiu f. Ai Zheng. 2004 Apr;23(4):461-6. Ai Zheng. 2004. PMID: 15087040 Clinical Trial. Chinese.
BACKGROUND & OBJECTIVE: Capecitabine is an oral fluoropyrimidine, which is converted to fluorouracil (5-FU) by exploiting the comparatively higher activity of thymidine phosphorylase (TP) in tumor tissue. ...
BACKGROUND & OBJECTIVE: Capecitabine is an oral fluoropyrimidine, which is converted to fluorouracil (5-FU) by exploiting the com …
[Phase I study of capecitabine with concurrent radiotherapy in early-stage nasopharyngeal carcinoma].
Guo L, Lin HX, Li FY, Li Q, Qiu F, Luo DH, Guo X, Hong MH. Guo L, et al. Among authors: qiu f. Zhonghua Zhong Liu Za Zhi. 2004 Apr;26(4):250-3. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15312392 Clinical Trial. Chinese.
This regimen is tolerable and valid for nasopharyngeal carcinoma. A randomised phase III comparison with 5-Fu is justified....
This regimen is tolerable and valid for nasopharyngeal carcinoma. A randomised phase III comparison with 5-Fu is justified....